These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9485053)

  • 1. "All fall down": the mechanism of orthostatic hypotension in multiple systems atrophy and Parkinson's disease.
    Saper CB
    Ann Neurol; 1998 Feb; 43(2):149-51. PubMed ID: 9485053
    [No Abstract]   [Full Text] [Related]  

  • 2. [Orthostatic hypotension and supine hypertension in primary autonomic failure. Pathophysiology, diagnosis and treatment].
    Tykocki T; Guzek K; Nauman P
    Kardiol Pol; 2010 Sep; 68(9):1057-63. PubMed ID: 20859904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy.
    Indelicato E; Fanciulli A; Poewe W; Antonini A; Pontieri FE; Wenning GK
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1393-7. PubMed ID: 26578037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Low PA; Parisi JE
    Brain; 2003 Oct; 126(Pt 10):2183-90. PubMed ID: 12902309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthostatic hypotension, balance and falls in Parkinson's disease.
    Matinolli M; Korpelainen JT; Korpelainen R; Sotaniemi KA; Myllylä VV
    Mov Disord; 2009 Apr; 24(5):745-51. PubMed ID: 19133666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of medullary regions controlling sympathetic output in Lewy body disease.
    Benarroch EE; Schmeichel AM; Low PA; Boeve BF; Sandroni P; Parisi JE
    Brain; 2005 Feb; 128(Pt 2):338-44. PubMed ID: 15634729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of medullary serotonergic groups in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Low PA; Parisi JE
    Ann Neurol; 2004 Mar; 55(3):418-22. PubMed ID: 14991820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of medullary serotonergic neurons in patients with multiple system atrophy who succumbed to sudden death.
    Tada M; Kakita A; Toyoshima Y; Onodera O; Ozawa T; Morita T; Nishizawa M; Takahashi H
    Brain; 2009 Jul; 132(Pt 7):1810-9. PubMed ID: 19429902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-system atrophy and medications: how to minimize the risk of falling.
    Kohli J; Brandt N
    Consult Pharm; 2011 Mar; 26(3):190-6. PubMed ID: 21402519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory?
    Jamnadas-Khoda J; Koshy S; Mathias CJ; Muthane UB; Ragothaman M; Dodaballapur SK
    Mov Disord; 2009 Sep; 24(12):1747-51. PubMed ID: 19562759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic dysfunction in Parkinson's disease.
    Micieli G; Tosi P; Marcheselli S; Cavallini A
    Neurol Sci; 2003 May; 24 Suppl 1():S32-4. PubMed ID: 12774210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Author response.
    Kohli J
    Consult Pharm; 2011 Jul; 26(7):450. PubMed ID: 24143845
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary disorders in Parkinson's disease and multiple system atrophy.
    Fowler CJ
    Funct Neurol; 2001; 16(3):277-82. PubMed ID: 11769873
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimizing the risk of falling.
    Lukazewski A
    Consult Pharm; 2011 Jul; 26(7):449-50. PubMed ID: 21729845
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple system atrophy which had been treated as juvenile Parkinson's disease].
    Yokochi F
    No To Shinkei; 2002 Mar; 54(3):267-75. PubMed ID: 11968820
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
    Coelho M; Ferreira J; Rosa M; Sampaio C
    Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure.
    Benarroch EE; Smithson IL; Low PA; Parisi JE
    Ann Neurol; 1998 Feb; 43(2):156-63. PubMed ID: 9485056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of branchimotor neurons of the nucleus ambiguus in multiple system atrophy.
    Benarroch EE; Schmeichel AM; Parisi JE
    Neurology; 2003 Jan; 60(1):115-7. PubMed ID: 12525730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary retention discriminates multiple system atrophy from Parkinson's disease.
    Fanciulli A; Goebel G; Lazzeri G; Granata R; Kiss G; Strano S; Colosimo C; Pontieri FE; Kaufmann H; Seppi K; Poewe W; Wenning GK
    Mov Disord; 2019 Dec; 34(12):1926-1928. PubMed ID: 31710392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.